Efficacy and Safety of Tenalisib in Patients With Metastatic Triple Negative Breast Cancer (TNBC)

NCT06189209 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Triple Negative Breast Cancer (TNBC)

Interventions

DRUG: Tenalisib

Sponsor

Rhizen Pharmaceuticals SA

Collaborators

[object Object]